BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240912T093000
DTEND;TZID=Europe/London:20240912T130000
DTSTAMP:20260409T011622
CREATED:20240723T192917Z
LAST-MODIFIED:20240906T091440Z
UID:31495-1726133400-1726146000@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: MedTech Strategic Innovation Gateway - The Future of Healthcare with AI
DESCRIPTION:                                                                                                                                                            With thanks to our event hosts:  \nThe Medilink Midlands Strategic Innovation Gateways create an environment for innovation\, knowledge exchange\, business opportunities and networking. \nDelivered in partnership with a select consortium of experts from academia\, clinicians and industry\, the Medilink Midlands Strategic Innovation Gateways (SIG) will help to create intelligence and data which will be used to inform policy making and influence national and regional strategies for the sector. \nMedilink Midlands invites you to join the second in the series of SIG events\, to expand your knowledge of the medtech space\, specifically\, the future of healthcare with Artificial Intelligence (AI). \nAs a region\, the Midlands houses one of the greatest health and life sciences clusters and the largest number of medtech companies in the UK\, with over 1\,200 life sciences businesses supporting over 33\,000 high skilled jobs\, and an economy worth more than £200bn a year. \nHome to rapidly growing cluster of digital health companies and more digital startups than any other UK area outside of London – the Midlands is the powerhouse for the medtech and life sciences industry. \nThis event offers a gateway to representatives who can offer support and guidance with medtech developments and innovations\, connect you with academic\, business and clinical communities to help forge collaborative partnerships. \nProgramme:  \n9:30am – Registrations and Refreshments  \n10:00am – Welcome and Introductions\, Professor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway \n10:05am – Transforming Healthcare Through AI-Powered Innovation\, Dr Junaid Arshad\, Professor in Cyber Security\, Birmingham City University \n10:15am – AI and Intellectual Property in Healthcare\, Simon Cooper\, Managing Director\, Adamson Jones\n– Why does it matter?\n– Opportunities and threats\n– Recent legal developments\, case studies and examples\n– Recommendations \n10:40am – Reimagining operating rooms with AI vision\, Maks Kozarzewski\, COO\, VitVio \n11:05am – Refreshments\, Break and Networking  \n11:30am – AI Regulations and Medical Devices: Artificial Hope or Intelligent Solution\, Richard Bassett\, Principal Regulatory Consultant\, DLRC\n– Exploring various types of AI and their applications in healthcare\n– Essential regulatory considerations for integrating AI into medical devices\n– The impact of AI Act and Medical Device Legislation on AI-driven healthcare innovations \n11:55 – Integrating AI and Human-Centred Design in Healthcare: A Path to Better Outcomes\, James Lomas\, Co-Founder/CTO\, Blüm Health Ltd \n12:20pm – Closing Remarks Professor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway \n12:30pm – Lunch and Networking \nCost and tickets: \nRegistrations are now closed. If you would like to book a ticket\, please email events@medilinkmidlands.com. \n£20 plus VAT for members of Medilink\n£40 plus VAT for non-members\n£10 plus VAT for students \nTo receive the member or student discount code email events@medilinkmidlands.com.\nPlease enter the code when you purchase your tickets and the amount will be amended automatically. \nSpeaker Profiles:\n\nMedTech SIG Chair: Professor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University\nPhilip holds multiple positions and interests surrounding medical technologies\, with his research interests and latest projects centred on new and emerging technologies and materials\, including surgical robotics\, extended reality technologies and environments\, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications. \n \nDr Junaid Arshad\, Professor in Cyber Security\, Birmingham City University\nJunaid is a Professor in Cyber Security at Birmingham City University. He has 15 years of research experience and expertise in investigating and addressing cybersecurity challenges for diverse computing paradigms such as High Performance Computing\, Cloud computing\, IoT\, and blockchain. He is actively engaged in investigating the opportunities and threats of Machine Learning and AI\, exploring the use of AI-based systems to address specific challenges as well as security and trustworthiness of ML and AI systems.\nJunaid is continuously engaged with businesses to support their needs especially with respect to digital transformation and trustworthy use of technological advancements to solve everyday problems. He has led number of projects in collaboration with industrial partners funded by Innovate UK and other third party funding agencies. He is currently leading BCU team for West Midlands Healthtech Innovation Accelerator (WMHTIA) project where the team is supporting 15+ Healthtech organisations within West Midlands region with their specific product development and technology enhancement needs\, many of which are focused on leveraging AI and ML to advance their products.\nJunaid is an alumnus of the Innovate UK & DCMS funded CyberASAP programme\, commercially prototyping the CyMonD system for effective monitoring & defence of IoT-based systems against cyber-threats. Junaid has successfully achieved research funding from UK and overseas funding agencies\, and has worked as a security specialist for a number of EU funded projects with experience of developing bespoke security solutions.  Junaid has successfully published high quality research within cybersecurity and has more than 70 publications at high quality venues including journals\, book chapters\, conferences and workshops. He regularly serves on editorial boards and programme committees of different journals and conferences. \n  \n \nSimon Cooper\, Managing Director\, Adamson Jones\nSimon is managing director of Adamson Jones\, a dedicated firm of patent and trade mark attorneys within the professional services group Gateley.\nSimon’s patent practice covers a wide range of different technologies\, but with a particular focus on medical devices\, including mechanical\, electrical\, and software-based technology for medical applications. Simon has particular experience working for successful\, innovative manufacturers and spin-out companies\, assisting his clients in navigating competitor IP rights\, and creating patent\, registered design and registered trade mark portfolios around valuable technology and product ranges. \n \nMaks Kozarzewski\, COO\, VitVio\nMaks is the COO at VitVio\, a startup using computer vision and AI to make operating rooms more efficient. Before joining VitVio\, Maks led UK’s top-ranked team competing in the SpaceX Hyperloop Pod Competition\, gaining him Forbes “25 under 25” title for his contributions to the space. He also developed medical diagnostic devices at a leading technology consultancy and has experience in public policy. He holds a Mechanical Engineering degree from the University of Edinburgh. \n\nRichard Bassett\, Principal Regulatory Consultant\, DLRC\nRichard is a medical device quality and regulatory professional\, with a comprehensive background encompassing the utilisation\, research\, and manufacturing of medical devices and in vitro diagnostics (IVDs). Currently serving as a Principal Regulatory Consultant at DLRC\, a renowned regulatory affairs consultancy with a team of over 80 highly qualified regulatory professionals\, Richard operates from the UK office\, contributing to DLRC’s success in strategically located offices across the UK\, Germany\, and the US. \nRichard brings over 14 years of extensive experience within the medical device industry. He has held roles including quality management\, regulatory compliance\, and clinical strategy development. His expertise extends to effective supplier engagement and guiding product development. Richard’s professional journey has traversed roles with a legal manufacturer\, consultancy positions\, and contributions to a Notified Body.  Richard holds a master’s degree in molecular biology\, complemented by a second master’s degree in medical law\, which specifically focused on UK and EU Medical Device Regulations. His dedication to sharing and imparting his knowledge is evident through his five-year tenure as a lecturer on medical device regulatory affairs at Cambridge University\, where he has made valuable contributions to the BioEnterprise MSc course.  As a Principal Regulatory Consultant at DLRC\, Richard continues to bring his wealth of knowledge and hands-on experience to navigate the complex landscape of medical device regulations\, contributing to DLRC’s reputation as an award-winning consultancy. \n\nJames Lomas\, Co-Founder/CTO\, Blüm Health Ltd\nJames has demonstrated a diverse and impactful career spanning several key positions. With over a decade of experience\, he has been pivotal in various leadership roles. At Blüm Heath\, he currently holds the position of Co-Founder and Chief Technical & Product Officer since October 2019. In this capacity\, he has built and advised the product and technical strategy\, whilst growing and managing the respective teams.\nJames has previously worked in leadership roles within large tech companies\, most recently at Blue Prism. Complex systems were a part of the Blue Prism software ecosystem\, pioneering the category of Robotic Process Automation\, a field recognised globally for its innovation\, with Blue Prism being voted into the MIT top 50 smartest companies from 2016-2021. James has successfully coordinated and delivered product leadership\, solution design and execution of the cloud portfolio of products during this period up until their acquisition by SS&C. He also championed and established the Design System with internal and external interactions within teams and customers for future products.\nHis expertise spans diverse sectors\, including Finance\, Venture Capital\, Banking\, FinTech\, and Health Tech. His extensive experience in project leadership\, coupled with his technical proficiency\, has enabled him to drive innovation and growth within these organisations. In the Finance and Venture Capital sectors\, he has collaborated with stakeholders to identify procedural frictions\, commercial opportunities\, and develop strategies aligning with market trends\, innovation landscape\, and financial goals. His contributions in Banking and FinTech involve developing technology-driven solutions to enhance financial services and customer experiences\, while ensuring regulatory compliance. In Health Tech\, as indicated by his work with clients like the NHS\, he focuses on integrating technology to improve healthcare delivery and outcomes. His experience working with both public and private companies has given him a deep understanding of various organisational structures and market dynamics. \nThis event is in collaboration with:  \n                 
URL:https://staging.medilinkmidlands.com/event/in-person-event-medtech-strategic-innovation-gateway/
LOCATION:STEAMHouse Birmingham\, Belmont Row\, Birmingham\, B4 7RQ\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240918T101500
DTEND;TZID=Europe/London:20240918T143000
DTSTAMP:20260409T011622
CREATED:20240731T144458Z
LAST-MODIFIED:20240904T102453Z
UID:31583-1726654500-1726669800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Growing the East of England Health and MedTech Cluster
DESCRIPTION:     \nAttention Health and MedTech companies: If you’re looking to accelerate your growth\, don’t miss this event hosted by Medilink Midlands and Health Tech Enterprise. \nWith over 20 years of experience supporting MedTech and Life Sciences companies\, we invite you to hear directly from industry leaders\, regional support organisations\, and businesses that have already benefited from our assistance. \nThis event is also your chance to influence the future of support in the East of England and contribute to shaping the vision of a MedTech Cluster in the region. \n“SEHTA is delighted to partner with Medilink Midlands to talk to the audience about how SEHTA can support SMEs in the East of England from the MedTech and Life Sciences sector” – Neil Roberts\, Managing Director\, SEHTA \nDon’t miss this opportunity to connect\, learn and have your voice heard! \nProgramme:  \n10:15am – Registrations\, Refreshments & Networking  \n11:00am – Host Welcome & Introduction\, James Fry\, Partner\, Head of Life Sciences\, Mills & Reeve \n11:05am – Strategic Overview & Welcome\, Melanie Davidson\, Chief Executive Officer\, Medilink Midlands & Dr Anne Blackwood\, CEO\, Health Tech Enterprise \n11:10am – The role of Health Innovation East in supporting companies to help generate improved heath and wealth in the East of England\, Philip Shelton\, Head of Industry Partnerships and Net Zero Lead\, Health Innovation East \n11:30am – Turning ideas into successful medical devices\, Danny Godfrey\, Co-Founder & Director\, eg technology \n11:50pm – Leveraging Support for Success: My Journey of Innovation in the NHS\, Dr Shaobin Wu\, Co-Founder\, C-Prio Ltd \n12:05pm – Refreshments & Networking \n12:20pm – Health Tech Enterprise Support\, Max Bardwell\, Head of Business Development\, Health Tech Enterprise \n12:25pm – Medilink Midlands Support\, Raghul Senthilnathan\, Innovation Adviser\, Medilink Midlands \n12:30pm – SEHTA Support for SMEs\, Neil Roberts\, Managing Director\, SEHTA \n12:35pm – Anglia Ruskin University Support\, Dr Beverley Vaughan\, Arise Innovation Hubs Director\, Anglia Ruskin University \n12:40pm – Group Breakouts: What support you would like to see in the East of England and what a MedTech Cluster would look like  \n13:15pm – Closing Remarks and Next Steps\, Melanie Davidson\, Chief Executive Officer\, Medilink Midlands \n13:25pm – Lunch & Networking  \nCLICK HERE TO BOOK YOUR PLACE*\nPlease ensure that you secure your free place\, as spaces are limited and available on a first come\, first served basis\, priority will be given to East of England organisations. \n*Spaces are now full\, to be added to the waiting list email: events@medilinkmidlands.com \nHosted by: \n \nSpeaker Profiles:\n \n\nJames Fry\, Partner\, Head of Life Sciences\, Mills & Reeve\nJames is a leading life sciences lawyer and heads the firm’s multi-disciplinary life sciences practice. He specialises in advising businesses and organisations in the sector on intellectual property matters and complex commercial contracting. In particular\, James has longstanding and deep knowledge of research and technology collaborations\, intellectual property licensing and the distribution and promotion of medical and medicinal products. He also regularly advises on regulatory issues relevant to the sector\, such as product classification\, clinical trials and advertising. His clients include GSK\, Illumina\, F-star\, The Binding Site\, NRG Therapeutics\, Mission Therapeutics and Neurocrine Biosciences. James has been ranked in the Intellectual Property sections of Chambers and Partners for many years. The Directories describe James as “an excellent lawyer” (Legal 500) and “an outstanding IP practitioner and life sciences specialist” (Chambers). \n\nMelanie Davidson\, Chief Executive Officer\, Medilink Midlands\nMelanie brings a background of industrial research and business development from West Pharmaceutical Service’s Drug Delivery Division. She also broadens our bioscience reach having studied Animal Science at The University of Nottingham. Before joining Medilink\, Melanie gained valuable experience in economic development and international investment at the East Midlands Development Agency (emda). \n\nDr Anne Blackwood\, CEO\, Health Tech Enterprise\nAnne is Chief Executive of Health Tech Enterprise (HTE)\, a leading NHS innovation and technology consultancy based in Cambridge. Anne has been actively involved in intellectual property management and commercialisation of life science technologies for over 20 years. She is also Chair of the Medtech Accelerator\, a joint venture with public sector partners that awards proof of concept funding to develop medical technologies that meet a clinical need in the NHS. She was formerly Chair and co-founder of Medovate\, a venture backed innovation development company dedicated to the commercialisation of medical technologies created within the NHS. Anne is passionate about improving the quality and efficiency of healthcare services through technology and innovation.\n \n\nPhilip Shelton PhD\, Head of Industry Partnerships and Net Zero Lead\, Health Innovation East \nPhilip joined Health Innovation East in 2020 from Philips and has over 20 years’ experience in life sciences\, NHS research and implementation and digital health. He specialises in AI and imaging and innovation focusing on helping the NHS reach their Net Zero targets.\nAs Head of Industry Partnerships and Net Zero Lead within our commercial team he is responsible for consulting and building a range of strategic partnerships with national and internation companies. These include Bayer\, Fujitsu\, Abbott and AstraZeneca. He is further supporting the two Imaging Networks in the East of England.  Philip also takes a lead role in the national Net Zero and sustainability portfolio and recently was commissioned to conduct two evaluation studies on Apollo Phase Change Solutions panels and the Net Zero benefits of the Abbott Indexor pre-analytics system. \n\nDanny Godfrey\, Co-Founder & Director\, eg technology\nDanny co-founded eg technology ltd in 2002\, with fellow director Andrew Ede. Based in Cambridge (UK)\, eg technology is a product design\, engineering and development consultancy\, specialising in the MedTech sector\, which has now grown to employ over 40 engineering and commercial staff.  With a BA and MEng in Engineering from Cambridge University and more than 20 years’ experience in product design and engineering\, Danny’s role is to provide corporate leadership\, develop new business opportunities and oversee the technical and strategic direction of projects. He has in depth knowledge of the entire project life cycle\, from the initial proposal writing\, technical & creative input\, design implementation\, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright\, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company. \n \nDr Shaobin Wu\, Co-Founder\, C-Prio Ltd \nDr. Shaobin Wu is a Consultant Histopathologist and the newly appointed Trust Clinical Lead for Genomics at East Suffolk and North Essex Foundation Trust. With a deep passion for healthcare innovation\, Dr. Wu has played a key role in advancing digital transformation within the NHS. As a Topol Digital Fellow and NHS Clinical Entrepreneur\, she has developed valuable skills in agile project management\, person-centred design\, and the integration of digital technologies in healthcare.\nIn addition to her clinical roles\, Dr. Wu is the Co-founder of C-Prio Ltd\, where she takes the leadership role to leverage AI and automation to address critical challenges in NHS histopathology service\, particularly in cancer diagnostics. Her entrepreneurial journey is distinguished by the strategic support and funding she has received from the Arise ABOVE program\, which have been instrumental in progressing her visionary ideas towards impactful solutions. Through her leadership and commitment\, Dr. Wu continues to push the boundaries of what’s possible in healthcare\, making meaningful contributions to both clinical practice and the broader entrepreneurial landscape. \n\nMax Bardwell\, Head of Business Development\, Health Tech Enterprise\nAn experienced professional in technology development and innovation\, Max Bardwell joined HTE in 2022 as Head of Business Development. His role is varied and includes developing new commercial partnerships\, opening up new market opportunities and driving sales growth.  Max has 20 years of experience in the development of scientific instrumentation and medical technologies and has worked for number of higher education institutions and spin out companies in research\, technology transfer and commercialisation of technology innovations. He has experience in the protection and exploitation of intellectual property\, project management and effective collaborative strategic partnership between industry and academia.  Max has a BSc in Chemistry from Nottingham Trent University\, an MBA from the Open University and a PhD in Atmospheric Chemistry from Nottingham Trent University. \n\nRaghul Senthilnathan\, Innovation Adviser\, Medilink Midlands\nRaghul is a dynamic Innovation Adviser with a master’s degree in Biotech and Pharma Management from UCL\, he has a very strong background in life sciences and healthcare innovation.  He has successfully founded two innovative start ups and has personal expertise in digital technologies. Raghul is skilled in leading accelerator programmes and supporting early stage companies to navigate challenges and realise their potential in contributing to the economy.  He also has expertise in coaching\, mentoring and business diagnostics to help innovators avoid pitfalls and succeed. \n \nNeil Roberts\, Managing Director\, SEHTA \nNeil has been the Managing Director since April 2021\, having previously been COO since July 2018. In July 2022\, Neil was appointed non-executive Chairman to the Board of Exhalation Technology Ltd\, which has attracted more than £11m in investor funding. In addition he is a business Mentor at Imperial College\, London\, as part of the Imperial Venture Mentoring Service.\nBased on more than 30 years as a Senior Executive in the medical technology market\, he has a track record of success in driving business development and growth\, via sales and marketing\, domestic and international distributor management\, market access\, major accounts\, new business integration\, and change management. This has been gained in the UK and in export both within an SME and market leading corporate environment.  His approach is based on pragmatism\, enabled by detailed market understanding\, with the highest importance placed on the execution of consequent action plans as the key to success.  He has managed product though NICE Technology Appraisal (TA)\, and other market access processes.  Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK\, and as Chair of the Ophthalmic Special Interest Group at the ABHI.  A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership studies at Harvard. \n\nDr Beverley Vaughan\, Arise Innovation Hubs Director\, Anglia Ruskin University\nBeverley joined the Arise Innovation Hubs as Director in June 2021\, with over 20 years’ experience in the healthcare and life sciences sector. Beverley trained as a clinical scientist in Haematology and working at Cambridge and London University Hospitals.  Working in the innovation sector for the last 10 years with roles in Stevenage Bioscience Catalyst (SBC)\, Cell and Gene Therapy Catapult (CGT) and the University of Oxford.  Whilst at SBC Beverley supported the development of translational research facilities and raised funding from multiple pharma and biotech companies for the Open Innovation Challenge in Neurodegeneration. At CGT Beverley managed a wide portfolio of project from novel drug discovery spin outs to NHS led delivery of cell therapy products. Most recently she was responsible for the delivery of a drug discovery consortium-UKSPINE- pivoting traditional pathways to meet the demands of healthy aging with partners\, Universities of Oxford\, Dundee and Birmingham\, Medicines Discovery Catapult\, The Francis Crick Institute and Sanger Centre Cambridge.  Since joining Arise as Director Beverley has been working on building the life science strategy for their newest hub located on the Harlow Innovation Park\, leading on strategy\, fund raising and partnering activities to build a cluster of expertise within this synapse of the London-Cambridge corridor. She is also a member of the NC3Rs CRACKIT advisory panel.
URL:https://staging.medilinkmidlands.com/event/in-person-event-growing-the-east-of-england-health-and-medtech-cluster/
LOCATION:Mills & Reeve LLP\, Botanic House\, 100 Hills Road\, Cambridge\, CB2 1PH\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240919T090000
DTEND;TZID=Europe/London:20240919T120000
DTSTAMP:20260409T011622
CREATED:20240805T095700Z
LAST-MODIFIED:20240827T083506Z
UID:31669-1726736400-1726747200@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Medilink Midlands Members Forum
DESCRIPTION:Quarterly Member Forums are an ideal opportunity for members to connect\, generate ideas and hear first-hand updates around Medilink Midlands activity. A chance to have your voice heard and input into how your membership can better support our network within the Med-Tech and Life Science Sector. \nThe next member forum will include an update and round-up of Medilink Midlands activity from Chris Dyke\, Head of Connectivity and Joanne Maltby\, Head of Projects. \nWe’re keen to hear from our members in terms of the Medilink Midlands Events Programme. We want to ensure we’re continuously developing and offering events which are informative and fun! And so there’s an opportunity to give your input via roundtable discussion which will be held by our newly appointed Events Manager\, Linsey Horsepool. \nMember and host\, Adamson Jones are patent and trade mark attorneys\, specialising in obtaining intellectual property rights for businesses and organisations in the UK\, Europe and throughout the world\, and will share their insights into how they can support members. So\, if you have any IP questions\, this is your chance to ask the experts! \nImportantly\, Adamson Jones will be hosting a mini session which will cover information around the new IP Advance Funding. Find out more about the fund here.  \nIf the invite to this Medilink Midlands member only event hasn’t reached your inbox\, please email events@medilinkmidlands.com to receive the details and booking link.  Online registration is essential. 
URL:https://staging.medilinkmidlands.com/event/in-person-event-medilink-midlands-members-forum-2-2/
LOCATION:Adamson Jones part of Gately\, Park View House\, 58 The Ropewalk\, Nottingham\, Nottinghamshire\, NG1 5DW\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR